Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Arbele Limited
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
China Medical University Hospital
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
National Cancer Institute (NCI)
RasCal Therapeutics, Inc.
National Cancer Institute (NCI)
Washington University School of Medicine
National Cancer Institute (NCI)
EMD Serono
Vividion Therapeutics, Inc.
National Cancer Institute (NCI)
BeOne Medicines
BeOne Medicines
AstraZeneca
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Dong-A ST Co., Ltd.
Continuity Biosciences, LLC
National Cancer Institute (NCI)
Boehringer Ingelheim
Washington University School of Medicine
University of Southern California
Boehringer Ingelheim
West China Hospital
Seagen Inc.
Medical College of Wisconsin
Incyte Corporation
National Cancer Institute (NCI)
Shanghai Henlius Biotech
Hoffmann-La Roche
Compass Therapeutics
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Seagen Inc.
Seagen Inc.
Eli Lilly and Company